The core ingredients are Methionine, Inositol, and Choline (MIC), which work synergistically to support liver function, prevent fat accumulation, and convert fat into usable energy
Better for long-term use
According to US obesity treatment guidelines, clinicians should consider whether to continue therapy if a patient has not lost at least 5% of baseline weight after approximately 3 months on the maintenance dose
The prospective Nersessian et al
Low GI TEAEs rates were observed with the most common being nausea (11.9% at 10 mg, 22.7% at 25 mg, 20.0% at 50 mg), diarrhea (4.8% at 10 mg, 20.5% at 25 mg, and 5% at 50 mg), and vomiting (2.4% at 10 mg, 11.4% at 25 mg, and 7.5% at 50 mg), generally consistent with the results of the Phase 1 trial of ribupatide oral conducted by Hengrui in China